Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. [electronic resource]
Producer: 19960806Description: 957-63 p. digitalISSN:- 0887-6924
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Asparaginase -- administration & dosage
- Base Sequence
- Child
- Child, Preschool
- Chromosomes, Human, Pair 22
- Chromosomes, Human, Pair 9
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Disease-Free Survival
- Female
- Fusion Proteins, bcr-abl -- genetics
- Germany
- Humans
- Incidence
- Infant
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Mercaptopurine -- administration & dosage
- Methotrexate -- administration & dosage
- Molecular Sequence Data
- Polymerase Chain Reaction
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prednisone -- administration & dosage
- Prognosis
- Prospective Studies
- Transcription, Genetic
- Translocation, Genetic
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.